Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
Minal K. Patel, MD, from the World Health Organization, answered our questions about her team’s research on the continued progress toward regional and global measles elimination from 2000 to 2018.
Sachiko Ozawa, PhD, MHS—the lead author of a new review that aimed to define hard-to-reach and hard-to-vaccinate populations—answers our questions about her latest review and about vaccine hesitancy.
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
A new study examined the relative contributions of pre-ART drug resistance mutations vs nonadherence in the etiology of elevated viral loads among pregnant women with HIV who initiate ART. Lead author...
Eugenia L. Siegler, MD, answers our questions about her approach to managing older adults with HIV, the challenges she and the older population face, and how to overcome those challenges.
The Heart Rhythm Society recently led an international survey of more than 1100 EP professionals to gauge how cardiac arrhythmias are being managed among patients hospitalized with COVID-19. Rakesh...
New preliminary findings indicate that gender identity may influence pain sensation more than genetic sex among individuals with HIV and chronic pain. Infectious Diseases Consultant discussed these findings...
Post-acute sequelae of SARS-CoV-2 are becoming an increasing concern for many patients with a history of COVID-19 infection. Moreover, these sequelae are often nonpulmonary in nature. In this Q&A, Dr...
As the COVID-19 vaccines are distributed across the United States, questions arise around vaccine hesitancy, local and state guidelines, and supply and demand. In this Q&A, Dr Evans addresses our...
